Miss Sholeh Feizi
Research Coordinator
School of Medicine
College of Health
Sholeh completed her PhD with the ENT Surgery group in 2022. Her research focuses on cellular biology and microbiology techniques, including designing and conducting experiments, animal work, and clinical trials.
| Date | Position | Institution name |
|---|---|---|
| 2021 - ongoing | Postdoctoral Researcher | University of Adelaide |
| 2018 - 2021 | Higher Degree by Research Candidate | University of Adelaide |
| Language | Competency |
|---|---|
| English | Can read, write, speak, understand spoken and peer review |
| Persian | Can read, write, speak, understand spoken and peer review |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2018 - 2021 | University of Adelaide | Australia | PhD |
| 2013 - 2015 | Alzahra University | Iran | MSc |
| 2008 - 2012 | Shahid Beheshti University | Iran | BSc |
| Year | Citation |
|---|---|
| 2026 | Awad, M., Bouras, G., Feizi, S., Grigson, S. R., Wormald, P. J., Psaltis, A. J., & Vreugde, S. (2026). LicD-mediated cell wall decoration governs phage sensitivity in Enterococcus faecalis clinical isolates. Microbiological Research, 302, 14 pages. |
| 2025 | Hall, J., Psaltis, A., Vreugde, S., Feizi, S., Chuah, Y., Alsharifi, M., & Ramezanpour, M. (2025). Effects of influenza A infection on liberation of bacteria from biofilms and inflammatory response in an in vitro model of chronic rhinosinusitis.. Microbiology (Reading), 171(8), 9 pages. |
| 2025 | Nepal, R., Houtak, G., Bouras, G., Feizi, S., Shaghayegh, G., Shearwin, K., . . . Vreugde, S. (2025). A φSa3int (NM3) Prophage Domestication in Staphylococcus aureus Leads to Increased Virulence Through Human Immune Evasion.. MedComm, 6(8), e70313. Scopus1 WoS1 Europe PMC1 |
| 2025 | Feizi, S., Cooksley, C. M., Reyne, N., Boog, B., Finnie, J., Shaghayegh, G., . . . Vreugde, S. (2025). An immunocompetent rat model of Mycobacterium abscessus multinodular granulomatous lung infection. Tuberculosis, 152, 102629-1-102629-8. Scopus2 WoS2 Europe PMC1 |
| 2025 | Fong, S. A., Bouras, G., Houtak, G., Nepal, R., Feizi, S., Morales, S., . . . Vreugde, S. (2025). Genomic variation in Pseudomonas aeruginosa clinical respiratory isolates with de novo resistance to a bacteriophage cocktail. Microbiology Spectrum, 13(5), e02149-24-1-e02149-24-22. |
| 2024 | Murphy, W., Liu, S., Javadiyan, S., Vyskocil, E., Feizi, S., Callejas, C., . . . Psaltis, A. J. (2024). An In Vitro Study Evaluating the Safety of Mesalazine on Human Nasoepithelial Cells. International Journal of Molecular Sciences, 25(5), 2796. Scopus2 WoS2 Europe PMC1 |
| 2024 | Murphy, W., Liu, S., Hon, K., Finnie, J., Bouras, G. S., Feizi, S., . . . Psaltis, A. J. (2024). A Novel Model of Staphylococcus aureus-Induced Lymphoplasmacytic Rhinosinusitis in Rats. International Journal of Molecular Sciences, 25(6), 3336-1-3336-13. Scopus1 WoS1 Europe PMC1 |
| 2024 | Shaghayegh, G., Cooksley, C., Bouras, G., Panchatcharam, B. S., Feizi, S., Javadian, S., . . . Vreugde, S. (2024). S. aureus biofilm properties correlate with immune B cell subset frequencies and severity of chronic rhinosinusitis. Clinical Immunology, 263, 110221-1-110221-16. Scopus3 WoS3 Europe PMC2 |
| 2024 | Tuli, J. F., Ramezanpour, M., Cooksley, C., Bouras, G. S., Ogi, K., Feizi, S., . . . Vreugde, S. (2024). Increased antibiotic resistance of Pseudomonas aeruginosa isolates from chronic rhinosinusitis patients grown in anaerobic conditions. Laryngoscope Investigative Otolaryngology, 9(3), e1244-1-e1244-9. Scopus2 WoS3 Europe PMC4 |
| 2024 | Ramezanpour, M., Feizi, S., Arachchige, H. D. P., Bouras, G., Cooksley, C., Shaghayegh, G., . . . Vreugde, S. (2024). Evaluation of mucosal barrier disruption due to Staphylococcus lugdunensis and Staphylococcus epidermidis exoproteins in patients with chronic rhinosinusitis. International Forum of Allergy and Rhinology, 15(3), 267-277. Scopus1 WoS1 |
| 2024 | Feizi, S., Awad, M., Ramezanpour, M., Cooksley, C., Murphy, W., Prestidge, C. A., . . . Vreugde, S. (2024). Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against <i>Mycobacterium abscessus</i> Intracellular Infection with Lipid Liquid Crystalline Nanoparticles.. ACS applied materials & interfaces, 16(51), 70274-70283. Scopus1 WoS1 Europe PMC1 |
| 2023 | Feizi, S., Cooksley, C. M., Ramezanpour, M., Nepal, R., Psaltis, A. J., Wormald, P. -J., & Vreugde, S. (2023). Colloidal silver against macrophage infections and biofilms of atypical mycobacteria.. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 36(4), 913-925. Scopus11 WoS10 Europe PMC4 |
| 2023 | Nepal, R., Houtak, G., Bouras, G., Ramezanpour, M., Feizi, S., Shaghayegh, G., . . . Vreugde, S. (2023). Prophage acquisition by<i>Staphylococcus aureus</i>contributes to the expansion of Staphylococcal immune evasion. |
| 2023 | Feizi, S., Awad, M., Nepal, R., Cooksley, C. M., Psaltis, A. J., Wormald, P. -J., & Vreugde, S. (2023). Deferiprone-gallium-protoporphyrin (IX): A promising treatment modality against Mycobacterium abscessus.. Tuberculosis (Edinburgh, Scotland), 142, 102390. Scopus3 WoS3 Europe PMC1 |
| 2022 | Feizi, S., Cooksley, C. M., Nepal, R., Psaltis, A. J., Wormald, P. -J., & Vreugde, S. (2022). Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients. Pathology, 54(4), 453-459. Scopus34 WoS32 Europe PMC19 |
| 2021 | Feizi, S., Cooksley, C. M., Bouras, G. S., Prestidge, C. A., Coenye, T., Psaltis, A. J., . . . Vreugde, S. (2021). Colloidal silver combating pathogenic Pseudomonas aeruginosa and MRSA in chronic rhinosinusitis.. Colloids and surfaces. B, Biointerfaces, 202, 1-10. Scopus20 WoS21 Europe PMC14 |
| 2021 | Feizi, S., Javadiyan, S., Cooksley, C. M., Shaghayegh, G., Psaltis, A. J., Wormald, P., & Vreugde, S. (2021). Green synthesized colloidal silver is devoid of toxic effects on primary human nasal epithelial cells in vitro. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 157, 112606-1-112606-10. Scopus9 WoS7 Europe PMC3 |
| 2018 | Feizi, S., Taghipour, E., Ghadam, P., & Mohammadi, P. (2018). Antifungal, antibacterial, antibiofilm and colorimetric sensing of toxic metals activities of eco friendly, economical synthesized Ag/AgCl nanoparticles using Malva Sylvestris leaf extracts. Microbial Pathogenesis, 125, 33-42. Scopus59 WoS49 Europe PMC26 |
| 2017 | Abbasi, Z., Feizi, S., Taghipour, E., & Ghadam, P. (2017). Green synthesis of silver nanoparticles using aqueous extract of dried Juglans regia green husk and examination of its biological properties. Green Processing and Synthesis, 6(5), 477-485. Scopus53 WoS41 |
| Year | Citation |
|---|---|
| 2025 | Awad, M., Bouras, G., Feizi, S., Grigson, S., Wormald, P. -J., Psaltis, A., & Vreugde, S. (2025). LicD-Mediated Cell Wall Decoration Governs Phage Sensitivity in Enterococcus faecalis Clinical Isolates. DOI |
Connect With Me
External Profiles
